Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

Chen PC, Lin HD.

Libyan J Med. 2012;7. doi: 10.3402/ljm.v7i0.19572. Epub 2012 Oct 24. No abstract available.

PMID:
23105951
[PubMed]
Free PMC Article
3.

Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.

Nakayama T, Watanabe M, Teramoto T, Kitajima M.

Anticancer Res. 1997 Mar-Apr;17(2B):1379-82.

PMID:
9137502
[PubMed - indexed for MEDLINE]
4.

[CEA, CA-19-9 and il-8, sTNFRII and sil-2R in persons at high risk of colorectal cancer].

Grotowski M, Wojtuń S.

Pol Merkur Lekarski. 2003 Apr;14(82):327-30. Polish.

PMID:
12868194
[PubMed - indexed for MEDLINE]
5.

Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR.

World J Gastroenterol. 2004 Feb 1;10(3):427-32.

PMID:
14760772
[PubMed - indexed for MEDLINE]
Free Article
6.

[Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].

Deguchi H, Tabuchi Y, Saitoh Y.

Nihon Geka Gakkai Zasshi. 1988 May;89(5):671-83. Japanese.

PMID:
3166103
[PubMed - indexed for MEDLINE]
7.

[Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].

Grotowski M, Maruszyński M, Piechota W.

Pol Merkur Lekarski. 2001 Dec;11(66):476-9. Polish.

PMID:
11899841
[PubMed - indexed for MEDLINE]
8.

[Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in gastric cancer patients].

Tabuchi Y, Deguchi H, Saitoh Y.

Nihon Geka Gakkai Zasshi. 1988 Aug;89(8):1181-91. Japanese.

PMID:
3185486
[PubMed - indexed for MEDLINE]
9.

[Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].

Changchine CS, Yung CY, Tzen KY.

Changgeng Yi Xue Za Zhi. 1991 Mar;14(1):32-8. Chinese.

PMID:
2039968
[PubMed - indexed for MEDLINE]
10.

Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.

Ohuchi N, Takahashi K, Matoba N, Sato T, Taira Y, Sakai N, Masuda M, Mori S.

Jpn J Clin Oncol. 1989 Sep;19(3):242-8.

PMID:
2810823
[PubMed - indexed for MEDLINE]
11.

[Expression and clinical significance of type-1 blood group antigens (Lea, Leb, CA19-9) in colorectal cancer--comparison with CEA].

Kiriyama K, Watanabe T, Sakamoto J, Ito K, Akiyama S, Yamauchi M, Takagi H.

Nihon Geka Gakkai Zasshi. 1991 Mar;92(3):320-30. Japanese.

PMID:
1675759
[PubMed - indexed for MEDLINE]
12.

Prognostic values of preoperative and postoperative CEA and CA19.9 levels in pancreatic cancer.

Yasue M, Sakamoto J, Teramukai S, Morimoto T, Yasui K, Kuno N, Kurimoto K, Ohashi Y.

Pancreas. 1994 Nov;9(6):735-40.

PMID:
7846017
[PubMed - indexed for MEDLINE]
13.

Prognostic values of serum CA19-9 and CEA levels for colorectal cancer.

Nakayama T, Watanabe M, Teramoto T, Kitajima M.

Oncol Rep. 1997 Jul-Aug;4(4):819-22.

PMID:
21590148
[PubMed]
14.

The effect of non-insulin-dependent diabetes on serum concentrations of tumor-associated carbohydrate antigens of CA19-9, CA-50, and sialyl SSEA-1 in association with the Lewis blood phenotype.

Shimojo N, Naka K, Nakajima C, Ishizaki T, Okuda K, Murai J, Yamamoto M.

Clin Chim Acta. 1990 Oct 15;190(3):283-9.

PMID:
1979260
[PubMed - indexed for MEDLINE]
15.

[CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia].

Shiota Y, Furuya K, Kitade M, Ueda N.

Nihon Kyobu Shikkan Gakkai Zasshi. 1989 Aug;27(8):887-93. Japanese.

PMID:
2615104
[PubMed - indexed for MEDLINE]
16.

The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.

Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, Kodaira S, Okajima K, Nakazato H; Tumor Marker Committee.

Gastric Cancer. 2003;6(3):142-5.

PMID:
14520526
[PubMed - indexed for MEDLINE]
17.

[A case of leptomeningeal carcinomatosis: demonstration of CA19-9 and CEA positive malignant cells in the CSF and particular elevation of CA19-9 level in the CSF].

Sato Y, Ohta Y, Ohtsuka T, Shoji H, Oizumi K.

Rinsho Shinkeigaku. 1991 Feb;31(2):175-8. Japanese.

PMID:
2060242
[PubMed - indexed for MEDLINE]
18.

Kinetics of carcinoembryonic antigen and carbohydrate antigen 19-9 production in a human pancreatic cancer cell line (SUIT-2).

Iwamura T, Katsuki T.

Gastroenterol Jpn. 1987 Oct;22(5):640-6.

PMID:
2445616
[PubMed - indexed for MEDLINE]
19.

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.

Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.

Eur J Surg Oncol. 2005 Mar;31(2):164-9.

PMID:
15698733
[PubMed - indexed for MEDLINE]
20.

Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma.

Qiu MZ, Lin JZ, Wang ZQ, Wang FH, Pan ZZ, Luo HY, Li YH, Zhou ZW, He YJ, Xu RH.

Int J Biol Markers. 2009 Oct-Dec;24(4):258-64.

PMID:
20082274
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk